PRDS
Price:
$2.18
Market Cap:
$135.19M
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.[Read more]
Industry
Biotechnology
IPO Date
2021-12-27
Stock Exchange
NASDAQ
Ticker
PRDS
According to Pardes Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.70. This represents a change of 19.87% compared to the average of -1.42 of the last 4 quarters.
The mean historical PE Ratio of Pardes Biosciences, Inc. over the last ten years is -0.89. The current -1.70 PE Ratio has changed 19.07% with respect to the historical average. Over the past ten years (40 quarters), PRDS's PE Ratio was at its highest in in the December 2022 quarter at -0.50. The PE Ratio was at its lowest in in the March 2021 quarter at -31.18.
Average
-0.89
Median
-1.05
Minimum
-1.61
Maximum
0
Discovering the peaks and valleys of Pardes Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -1.61
Year | PE Ratio | Change |
---|---|---|
2022 | -1.05 | -34.87% |
2021 | -1.61 | -Infinity% |
The current PE Ratio of Pardes Biosciences, Inc. (PRDS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.89
5-year avg
-0.89
10-year avg
-0.89
Pardes Biosciences, Inc.’s PE Ratio is less than Shattuck Labs, Inc. (-0.76), less than Eliem Therapeutics, Inc. (0), greater than Champions Oncology, Inc. (-178.90), less than Century Therapeutics, Inc. (-0.67), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than Instil Bio, Inc. (-1.89), less than Achilles Therapeutics plc (-0.69), less than NextCure, Inc. (-0.41), greater than Assembly Biosciences, Inc. (-2.29), less than CytomX Therapeutics, Inc. (6.58), less than Nuvation Bio Inc. (-1.45), greater than Ovid Therapeutics Inc. (-2.11), less than Connect Biopharma Holdings Limited (7.21),
Company | PE Ratio | Market cap |
---|---|---|
-0.76 | $52.99M | |
0 | $342.68M | |
-178.90 | $108.76M | |
-0.67 | $87.15M | |
-5.86 | $8.20M | |
-1.89 | $142.85M | |
-0.69 | $46.85M | |
-0.41 | $24.31M | |
-2.29 | $93.56M | |
6.58 | $83.74M | |
-1.45 | $949.12M | |
-2.11 | $68.62M | |
7.21 | $55.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pardes Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pardes Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pardes Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Pardes Biosciences, Inc. (PRDS)?
What is the highest PE Ratio for Pardes Biosciences, Inc. (PRDS)?
What is the 3-year average PE Ratio for Pardes Biosciences, Inc. (PRDS)?
What is the 5-year average PE Ratio for Pardes Biosciences, Inc. (PRDS)?
How does the current PE Ratio for Pardes Biosciences, Inc. (PRDS) compare to its historical average?